Skip Navigation

European Heart Journal 2000 21(8):611-613; doi:10.1053/euhj.1999.2014
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Muntwyler, J.
Right arrow Articles by Lüscher, T.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muntwyler, J.
Right arrow Articles by Lüscher, T.F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Assessment of cardiovascular risk: time to apply genetic risk factors?

J. Muntwyler and T.F. Lüscher

University Hospital, Zürich, Switzerland

References

  1. Grundy SM, Balady GJ, Criqui MH. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation. 1998;97:1876–1887[Free Full Text]
  2. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J. 1998;19:A2–11
  3. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847[Abstract/Free Full Text]
  4. Wannamethee SG, Shaper AG, Walker M. Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet. 1998;351:1603–1608[CrossRef][Web of Science][Medline]
  5. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet. 1998;352:1882–1885[CrossRef][Web of Science][Medline]
  6. Wei M, Mitchell BD, Haffner SM, Stern MP. Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol. 1996;144:1058–1065[Abstract/Free Full Text]
  7. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731–733[Abstract/Free Full Text]
  8. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635–641[Abstract/Free Full Text]
  9. Verhoef P, Stampfer MJ. Prospective studies of homocysteine and cardiovascular disease. Nutr Rev. 1995;53:283–288[Web of Science][Medline]
  10. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ. 1990;301:1248–1251[Abstract/Free Full Text]
  11. Miller DB. Secondary prevention for ischaemic heart disease. Relative numbers needed to treat with different therapies. Arch Intern Med. 1997;157:2045–2052[Abstract/Free Full Text]
  12. Goldman L, Coxson P, Hunink MG. The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines. J Am Coll Cardiol. 1999;34:768–776[Abstract/Free Full Text]
  13. Friedlander Y, Kark JD, Stein Y. Family history of myocardial infarction as an independent risk factor for coronary heart disease. Br Heart J. 1985;53:382–387[Abstract/Free Full Text]
  14. Keating M, Dunn C, Atkinson D, Timothy K, Vincent GM, Leppert M. Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet. 1991;49:1335–1339[Web of Science][Medline]
  15. Jarcho JA, McKenna W, Pare JA. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med. 1989;321:1372–1378[Abstract]
  16. Cambien F, Poirier O, Lecerf L. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641–644[CrossRef][Medline]
  17. Luscher TF. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. Basic Res Cardiol. 1993;88:15–24
  18. Mancini GB. Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease. Am J Med. 1998;105:40S–47S[CrossRef][Medline]
  19. Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol. 1990;137:7–12[Abstract]
  20. Sassono P, Chatellier G, Billaud E, Alhenc-Gelas F, Corvol P, Menard J. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial. Am J Med. 1987;83:227–235[CrossRef][Web of Science][Medline]
  21. N Engl J Med. 1987;316:1429–1435[Abstract]
  22. Circulation. 1998;97:2202–2212[Abstract/Free Full Text]
  23. Staessen JA, Wang JG, Ginocchio G. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15:1579–1592[CrossRef][Web of Science][Medline]
  24. Keavney B, McKenzie C, Parish S. Large-scale test of hypothesized associations between the ACE I/D polymorphism and MI in over 10,000 cases and controls (Abstr). Eur Heart J. 1999;20:143
  25. Holmer SR, Hengstenberg C, Mayer B. No association of the I/D polymorphism of the angiotensin-converting enzyme with myocardial infarction in 4941 probands (Abstr). Eur Heart J. 1999;20:143
  26. Fatini C, Abbate R, Pepe G. Searching for a better assessment of the individual coronary risk profile: the role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J. 2000;21:633–638[Abstract/Free Full Text]
  27. Tiret L, Bonnardeaux A, Poirier O. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994;344:910–913[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Muntwyler, J.
Right arrow Articles by Lüscher, T.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muntwyler, J.
Right arrow Articles by Lüscher, T.F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?